Skip to main content
Clinical Trials/EUCTR2019-003033-42-ES
EUCTR2019-003033-42-ESActive, not recruitingPhase 1

The impact of deep versus standard muscle relaxation on intra-operative safety during laparoscopic surgery: a multicenter strategy study – EURO RELAX STUDY - EURO RELAX STUDY

INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE0 sites230 target enrollmentStarted: December 20, 2019Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
230

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a patient must meet all of the following criteria:
  • Patients scheduled for elective laparoscopic procedure with a complexity according to the BUPA classification for case complexity: ‘MAJOR’, ‘MAJOR PLUS’ or ‘COMPLEX MAJOR’
  • ASA class I-III
  • > 18 years of age
  • Ability to give oral and written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 230
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Low or intermediate complexity laparoscopic procedures (BUPA ‘SIMPLE’ or ‘INTER’)
  • Known or suspected neuromuscular disorders impairing neuromuscular function
  • Allergies to muscle relaxants, anesthetics or narcotics
  • A (family) history of malignant hyperthermia
  • Women who are or may be pregnant or are currently breast feeding
  • Chronic use of any type of opioid or psychotropic drug
  • Use of NSAID’s shorter than 5 days before surgery
  • Indication for rapid sequence induction
  • Contra-indication for sugammadex use (e.g. known sugammadex allergy or GFR<30 ml/min)

Investigators

Sponsor
INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE

Similar Trials